Similar articles

• Inspections: the international regulatory view--Japan.

  Kamura S. Kamura S. PDA J Pharm Sci Technol. 1994 Jul-Aug;48(4):182-3. PDA J Pharm Sci Technol. 1994. PMID: 7804816 No abstract available.
• Counterfeiting and piracy of pharmaceuticals.

  Grackin A. Grackin A. IEEE Eng Med Biol Mag. 2008 Nov-Dec;27(6):66-9. doi: 10.1109/MEMB.2008.929891. IEEE Eng Med Biol Mag. 2008. PMID: 19004698 No abstract available.
• Licensing under the Medicines Act and its effect on pharmacy.

  Fishburn AG. Fishburn AG. R Soc Health J. 1974 Dec;94(6):271-3, 95. doi: 10.1177/146642407409400604. R Soc Health J. 1974. PMID: 4460083 No abstract available.
• Global perspective on specifications for biotechnology products--perspective from Japan.

  Hayakawa T. Hayakawa T. Dev Biol Stand. 1997;91:15-23. Dev Biol Stand. 1997. PMID: 9413678 Review. No abstract available.
• Internationalization of regulatory requirements.

  Juillet Y. Juillet Y. Fundam Clin Pharmacol. 2003 Feb;17(1):21-5. doi: 10.1046/j.1472-8206.2003.00118.x. Fundam Clin Pharmacol. 2003. PMID: 12588627 Review.